Comments on "Use of metformin and risk of kidney cancer in patients with type 2 diabetes", Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25
- PMID: 27131610
- DOI: 10.1016/j.ejca.2016.03.065
Comments on "Use of metformin and risk of kidney cancer in patients with type 2 diabetes", Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25
Comment in
-
Response to Letter to the Editor on comments on Use of metformin and risk of kidney cancer in patients with type 2 diabetes Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25.Eur J Cancer. 2016 Jul;61:159-60. doi: 10.1016/j.ejca.2016.03.064. Epub 2016 Apr 25. Eur J Cancer. 2016. PMID: 27133198 No abstract available.
Comment on
-
Use of metformin and risk of kidney cancer in patients with type 2 diabetes.Eur J Cancer. 2016 Jan;52:19-25. doi: 10.1016/j.ejca.2015.09.027. Epub 2015 Nov 26. Eur J Cancer. 2016. PMID: 26630530
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
